This Psilocybin Patent Could Be a Really Big Deal
Canna Law Blog
JANUARY 22, 2020
The company is also running a phase IIb clinical trial of its patented formulation, COMP360, which we covered in a blog post back in 2018. It seems unlikely, even if microdosing continues to trend. As I wrote previously, around 100 million individuals suffer from treatment-resistant depression worldwide.
Let's personalize your content